Table 2

Risk stratification for discontinuation of P2Y12 receptor antagonists clopidogrel, prasugrel or ticagrelor based on the risk of thrombosis

High risk of thrombosisLow risk of thrombosis
Drug eluting coronary artery stents within 12 months of placementIschaemic heart disease without coronary stents
Bare metal coronary artery stents within 1 month of placementCerebrovascular disease
Peripheral vascular disease